About Us

At TheraCarb, we believe it is our responsibility to pursue technologies that can benefit human disease prevention. TheraCarb is developing a pipeline of preclinical products designed to target underserved medical diseases which affect millions of people globally.

TheraCarb's business model is to build strategic partnerships with companies having aligned commitments to human health. Through positive on-going preclinical studies, TheraCarb's product candidates have shown significant potential to address growing multi-million dollar markets and are poised to replace existing less effective pharmaceutical therapies.

At TheraCarb, we believe.